LIXTE BIOTECHNOLOGY HOLDINGS, INC. (NMAD) Operating cash flow 2016–2025
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (NMAD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$3.1MFY2025 · since FY2016: -$1.7M → -$3.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.1M | +3.0% |
| FY2024 | -$3.2M | +26.3% |
| FY2023 | -$4.3M | +6.9% |
| FY2022 | -$4.6M | -11.3% |
| FY2021 | -$4.1M | -94.4% |
| FY2020 | -$2.1M | -227.3% |
| FY2019 | $1.7M | +210.8% |
| FY2018 | -$1.5M | -7.0% |
| FY2017 | -$1.4M | +15.8% |
| FY2016 | -$1.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice